PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5

@article{Fazio2013PAX5ETV6AT,
  title={PAX5/ETV6 alters the gene expression profile of precursor B cells with opposite dominant effect on endogenous PAX5},
  author={Grazia Fazio and Valeria Cazzaniga and Chiara Palmi and Marta Galbiati and Marco Giordan and Geertruy Te Kronnie and Antonius G. Rolink and Andrea Biondi and Giovanni Cazzaniga},
  journal={Leukemia},
  year={2013},
  volume={27},
  pages={992-995}
}
Oncol 1995; 13: 345–351. 2 Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 1999; 93: 2817–2823. 3 Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 2005; 293: 1485–1489. 4 Otterness D, Szumlanski C, Lennard L, Klemetsdal B… CONTINUE READING